Results 251 to 260 of about 95,577 (390)

Trends in Parkinson's disease medication prescribing patterns in the UK: An interrupted time series analysis (2019-2024). [PDF]

PLoS One
Orayj K.
europepmc   +1 more source

Impaired desynchronization of beta activity underlies memory deficits in people with Parkinson's disease

, 2019
Brittain, J., Hanslmayr, S., Jenkinson, N., MacDonald, H., Spitzer, B.   +4 more
core   +1 more source

High frequency stimulation of the subthalamic nucleus and levodopa induced dyskinesias in Parkinson's disease [PDF]

, 2000
José Á. Obeso
openalex   +1 more source

Wearable multimodal sensing for quantifying the cardiovascular autonomic effects of levodopa in parkinsonism. [PDF]

Front Netw Physiol
Berkebile JA, Inan OT, Beach PA.
europepmc   +1 more source

Informed Consent Procedure for Research Including Patients with Parkinson's Disease and Cognitive Impairment

Movement Disorders Clinical Practice, EarlyView.
Vibuthi Sisodia, Bart E.K.S. Swinnen, Evelien Lemstra, Gert J. Geurtsen, Albert F.G. Leentjens, Martin A.J.M. Buijsen, Maartje H.N. Schermer, Rob M.A. de Bie   +7 more
wiley   +1 more source

Observed and Patient‐Perceived Information Provision When Diagnosed With Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background People with Parkinson's disease (PD) perceive to receive insufficient disease‐specific information after diagnosis, whereas clinicians report providing all relevant information. Objectives The objectives were to examine the information actually provided by clinicians during diagnostic consultations and its relations with background ...
Elisabeth Kurpershoek, Marij A. Hillen, Mark H.B. Huisman, Machiel Pleizier, Annemarie Vlaar, Jeroen Blankevoort, Evelien Zoons, Dareia Selina Roos, Marianne de Visser, Rob M.A. de Bie, Joke M. Dijk   +10 more
wiley   +1 more source

Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's disease [PDF]

, 2000
Robert A. Hauser, William C. Koller, Jean Hubble, Teresita Malapira, Karen Busenbark, C. Warren Olanow   +5 more
openalex   +1 more source

Modulatory effect of levodopa on the basal ganglia-cerebellum connectivity in Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Yun JJ, Abulikemu S, Jangwanich KL, Tai YF, Haar S.   +4 more
europepmc   +1 more source

Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation [PDF]

, 2000
B. Paul Bejjani
openalex   +1 more source

Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progression. [PDF]

J Neural Transm (Vienna)
Riederer P, Strobel S, Nagatsu T, Watanabe H, Chen X, Löschmann PA, Sian-Hulsmann J, Jost WH, Müller T, Dijkstra JM, Monoranu CM.   +10 more
europepmc   +1 more source